Influence Of Real World Data In The Pharmaceutical Industry

Real-world evidence (RWE) research is essential for biopharmaceutical product development and commercialization. The pharmaceutical industry essentially depends on the information on a product’s real-world effectiveness and safety data. This information impacts the ensuing reimbursement and utilization of new products. Regulators, public and private payers, and prescribers, are all keen to know the impact of a new product in a real-world setting. The viewpoint for RWE generation is promising, with the potential to improve health outcomes and cost[1]effectiveness of new health technologies. The demand for RWE is increasing and is unlikely to subside as health care decision-makers become gradually aware of what it offers